Project Details
Description
A Phase 1b/2a, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Camoteskimab in Subjects with Still’s Disease (sJIA/AOSD)
| Status | Active |
|---|---|
| Effective start/end date | 5/15/23 → 5/31/28 |
Funding
- APOLLO THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.